July 15, 2013

The Food and Drug Administration has approved a generic opioid painkiller made by Actavis, the drug maker said.

July 15, 2013

Self-reported medication adherence rates increased among Type 2 diabetes patients using a mobile app, the maker of the app said Monday.

July 15, 2013

MinuteClinic has created a weight-loss program that incorporates what has been ranked as one of the top diets in the country.

July 15, 2013

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

July 15, 2013

The National Association of Specialty Pharmacy will begin developing pharmacy practice parameters in about 20 specialty therapeutic categories this year, the group said.

July 15, 2013

A team of scientists at The Wistar Institute has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century, researchers announced Monday.

July 12, 2013

Actavis is looking to become the first to market a generic drug for epilepsy, the company said.

July 12, 2013

A developer of revenue and payment cycle management and clinical information exchange software is expanding its payment network.

July 12, 2013

The Food and Drug Administration has approved a new lung cancer drug made by Boehringer Ingelheim, the agency said.

July 12, 2013

Giant Food is revamping a program designed to promote health and wellness among children, the supermarket chain said.

July 12, 2013

The Southern Illinois University Edwardsville School of Pharmacy has promoted pharmacy practice professor J. Mark Ruscin to chairman of the Department of Pharmacy Practice.

July 12, 2013

The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.

July 11, 2013

Legislation introduced in the Senate would coordinate efforts at various levels of government and industry to reduce the growing problem of prescription drug abuse.

July 11, 2013

The Food and Drug Administration has approved a Kremers Urban Pharmaceuticals drug for treating attention deficit hyperactivity disorder, the UCB subsidiary said.

July 11, 2013

Mylan is challenging a patent on a drug used to treat ulcerative proctitis, the generic drug maker said Thursday.

July 11, 2013

A Washington-based healthcare accrediting organization has given its nod to Avella Specialty Pharmacy, Avella said Thursday.

July 10, 2013

A new study by researchers at the University of Washington provides further evidence that most of the health problems affecting the country are linked to lifestyle choices.

July 10, 2013

A new app for Android and the Apple iPhone aims to combine technology with psychology to reduce poor patient adherence to medication therapies.

July 10, 2013

A system for confidentially storing patients' biometric data on a card made by PharmaSmart International has been added to several national drug databases, which the company said would aid support for hypertension patients among healthcare providers, health plans and pharmacists.

July 10, 2013

Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.

July 10, 2013

Pharmacists remotely monitoring patients helped them achieve better blood-pressure control than physicians in usual care, according to a new study.

July 9, 2013

Amgen will get rights to a drug for cardiovascular disease approved in the European Union under a new deal with French drug maker Servier, the two companies said.

July 9, 2013

A nonprofit pharmacy advocacy group has launched a new project that it said was aimed at ensuring fair audit standards for prescription drug claims paid under the Medicare Part D program and protecting pharmacies and patients from what it called unfair audit and conduct practices by pharmacy benefit managers.

July 9, 2013

The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.